Lamisil Once

Terbinafine, the active ingredient in Lamisil Once, is a Allylamine antifungal presented as a unknown/unknown for topical use. It treats superficial dermatophyte infections such as athlete's foot, jock itch and ringworm in both adults and children.

GNH USA supplies Lamisil Once as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terbinafine is an allylamine antifungal used to treat superficial dermatophyte infections.

- Tinea corporis: reduces fungal growth and clears the body rash. - Tinea cruris: eliminates the fungus causing jock itch and relieves itching. - Tinea pedis: clears athlete's foot by eradicating the causative dermatophytes.

Terbinafine may cause local skin reactions when applied topically.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Redness: localized erythema. - Burning: transient heat sensation. - Scaling: flaking of the treated skin. - Dryness: reduced skin moisture. - Irritation: mild discomfort or stinging.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Contact dermatitis: intense rash or blistering. - Urticaria: widespread hives. - Stevens-Johnson syndrome: rare severe skin disorder. - Swelling: pronounced edema of the treated area. - Blister formation: fluid‑filled lesions.

Before using Lamisil Once, consider the following safety measures.

- Pregnancy: consult a healthcare professional before application. - Breastfeeding: discuss potential risks with a doctor. - Age: follow pediatric guidance for children. - Skin condition: avoid use on broken or inflamed skin. - Allergy: discontinue if a severe reaction occurs. - Store at room temperature: keep in the original container, protect from moisture and light.

Terbinafine topical may interact with other medications or products.

Major Interactions (Avoid): - Systemic terbinafine: concurrent systemic therapy may increase overall exposure. - Strong CYP2D6 inhibitors: may raise terbinafine levels and risk systemic effects.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antifungal efficacy. - Other topical agents (e.g., salicylic acid): risk of increased skin irritation. - Alcohol‑based cleansers: may enhance local irritation when used together.